NO20005839L - Preparater for behandling av HIV og andre virale infeksjoner - Google Patents

Preparater for behandling av HIV og andre virale infeksjoner

Info

Publication number: NO20005839L
Authority: NO; Norway
Prior art keywords: hiv; virus; hydrogen; carbon atoms; prevent
Prior art date: 1998-05-19

Application number

NO20005839A

Other languages

English (en)

Norwegian (no)

Other versions

NO20005839D0 (no

Inventor

James Berger Camden

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-19

Filing date

2000-11-17

Publication date

2001-01-16

2000-11-17 Application filed by Procter & Gamble filed Critical Procter & Gamble

2000-11-17 Publication of NO20005839D0 publication Critical patent/NO20005839D0/no

2001-01-16 Publication of NO20005839L publication Critical patent/NO20005839L/no

Links

208000036142 Viral infection Diseases 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
230000009385 viral infection Effects 0.000 title abstract 2
241000725303 Human immunodeficiency virus Species 0.000 abstract 4
241000700605 Viruses Species 0.000 abstract 4
125000004432 carbon atom Chemical group C* 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
241000709661 Enterovirus Species 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
208000037357 HIV infectious disease Diseases 0.000 abstract 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
150000001556 benzimidazoles Chemical class 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
208000006454 hepatitis Diseases 0.000 abstract 1
231100000283 hepatitis Toxicity 0.000 abstract 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
206010022000 influenza Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
-1 nitro, oxychloro, methyl Chemical group 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
230000010076 replication Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
241001529453 unidentified herpesvirus Species 0.000 abstract 1
241000712461 unidentified influenza virus Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20005839A 1998-05-19 2000-11-17 Preparater for behandling av HIV og andre virale infeksjoner NO20005839L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8138498A	1998-05-19	1998-05-19
PCT/US1999/011059 WO1999059585A1 (en)	1998-05-19	1999-05-19	Compositions for the treatment of hiv and other viral infections

Publications (2)

Publication Number	Publication Date
NO20005839D0 NO20005839D0 (no)	2000-11-17
NO20005839L true NO20005839L (no)	2001-01-16

Family

ID=22163807

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005839A NO20005839L (no)	1998-05-19	2000-11-17	Preparater for behandling av HIV og andre virale infeksjoner

Country Status (19)

Country	Link
US (1)	US6245789B1 (id)
EP (1)	EP1079831A1 (id)
JP (1)	JP2002515432A (id)
KR (1)	KR20010043709A (id)
CN (1)	CN1301158A (id)
AR (1)	AR019305A1 (id)
AU (1)	AU4004299A (id)
BR (1)	BR9911043A (id)
CA (1)	CA2329877A1 (id)
CO (1)	CO5050303A1 (id)
HU (1)	HUP0103319A2 (id)
ID (1)	ID27457A (id)
IL (1)	IL139002A0 (id)
NO (1)	NO20005839L (id)
PE (1)	PE20000550A1 (id)
PL (1)	PL344223A1 (id)
SK (1)	SK17442000A3 (id)
TR (1)	TR200003383T2 (id)
WO (1)	WO1999059585A1 (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6479526B1 (en)	1995-04-12	2002-11-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en)	1995-04-12	2001-01-23	The Procter & Gamble Company	Method of treatment for cancer or viral infections
US6262093B1 (en)	1995-04-12	2001-07-17	The Proctor & Gamble Company	Methods of treating cancer with benzimidazoles
US6265427B1 (en)	1995-06-07	2001-07-24	The Proctor & Gamble Company	Pharmaceutical composition for the method of treating leukemia
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en)	1995-08-04	2004-02-03	University Of Arizona Foundation	N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment
US6423734B1 (en) *	1999-08-13	2002-07-23	The Procter & Gamble Company	Method of preventing cancer
US6242461B1 (en) *	2000-01-25	2001-06-05	Pfizer Inc.	Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US6380232B1 (en)	2000-09-26	2002-04-30	The Procter & Gamble Company	Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en)	2000-09-26	2003-08-19	University Of Arizona Foundation	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) *	2000-09-26	2002-06-18	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en)	2000-09-26	2002-10-08	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002239395A1 (en) *	2000-11-01	2002-06-03	The Procter And Gamble Company	Hiv treatment with benzimidazoles
US7163940B2 (en)	2000-12-15	2007-01-16	Smithkline Beecham Corporation	Pyrazolopyridinyl pyrimidine therapeutic compounds
DE60112609T2 (de)	2000-12-15	2006-01-19	Glaxo Group Ltd., Greenford	Pyrazolopyridine
ES2227451T3 (es)	2001-03-08	2005-04-01	Smithkline Beecham Corporation	Derivados de pirazolopiridina.
JP4237497B2 (ja)	2001-03-30	2009-03-11	スミスクラインビーチャムコーポレーション	ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
WO2002083672A1 (en)	2001-04-10	2002-10-24	Smithkline Beecham Corporation	Antiviral pyrazolopyridine compounds
EP1385847B1 (en)	2001-04-27	2005-06-01	SmithKline Beecham Corporation	Pyrazolo[1,5-a]pyridine derivatives
IL158667A0 (en)	2001-06-21	2004-05-12	Smithkline Beecham Corp	Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections
ES2262893T3 (es)	2001-10-05	2006-12-01	Smithkline Beecham Corporation	Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
US7199120B2 (en)	2001-12-11	2007-04-03	Smithkline Beecham Corporation	Pyrazolo-pyridine derivatives as antiherpes agents
AU2003220585A1 (en) *	2002-03-26	2003-10-13	Arizona Board of Regents on behalf of the University of Arizone	Solubilization of weak bases
US7153863B2 (en)	2002-10-03	2006-12-26	Smithkline Beecham Corporation	Therapeutic compounds based on pyrazolopyridline derivatives
AU2003900064A0 (en) *	2003-01-09	2003-01-23	Penam Investments Pty. Ltd.	A method of treatment or prophylaxis of viral infection.
JP2005060362A (ja) *	2003-07-28	2005-03-10	Shionogi & Co Ltd	セスキテルペン誘導体を含有する抗ＨＩＶ剤、抗ＢＶＤＶ剤、抗ＨＣＶ剤又は抗ＣｏＶ剤
EP2251010A1 (en)	2009-05-08	2010-11-17	Sygnis Bioscience GmbH & Co. KG	Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
EP2968543B1 (en) *	2013-03-15	2024-08-07	Camas Incorporated	Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
FR3057865A1 (fr) *	2016-10-21	2018-04-27	Laboratoire Michel Iderne	Composition chimique
TW201936193A (zh) *	2017-12-05	2019-09-16	愛爾蘭商健生科學愛爾蘭無限公司	使用組合產品治療ｒｓｖ
KR102342313B1 (ko) *	2021-08-27	2021-12-24	(주)바이오메트릭스 테크놀로지	벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3010968A (en)	1959-11-25	1961-11-28	Du Pont	Process for manufacture of certain alkyl esters of benzimidazole carbamic acids
NL134354C (id)	1963-05-23
US3499761A (en)	1964-07-20	1970-03-10	Gaf Corp	Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents
US3541213A (en)	1966-05-06	1970-11-17	Du Pont	Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles
US3881014A (en)	1968-11-05	1975-04-29	Bayer Ag	N-tritylimidazoles for treating fungal infections
BE759337A (fr)	1969-11-24	1971-05-24	Lilly Co Eli	Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones
US3956262A (en)	1970-12-09	1976-05-11	Beecham Group Limited	Triazenoimidazoles
US3738995A (en)	1971-05-14	1973-06-12	Du Pont	Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates
FR2155888A1 (en)	1971-10-13	1973-05-25	Agot Aime	Solid anthelmintic composn - for more economical treatment of ruminants
US4046906A (en)	1973-04-21	1977-09-06	Hoechst Aktiengesellschaft	Salts of alkyl 2-benzimidazole-carbamate
HU193951B (en)	1985-03-11	1987-12-28	Richter Gedeon Vegyeszet	Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
US4731366A (en)	1986-08-05	1988-03-15	Harbor Branch Oceanographic Institution, Inc.	Discorhabdin compositions and their methods of use
GB2210875B (en)	1987-10-09	1991-05-29	Farmos Oy	Aromatase inhibiting 4(5)-imidazoles
US5329012A (en)	1987-10-29	1994-07-12	The Research Foundation Of State University Of New York	Bis(acyloxmethyl)imidazole compounds
US5114951A (en)	1989-04-11	1992-05-19	Burroughs Wellcome Company	Agents for combating multiple drug resistance
US5149527A (en)	1990-09-18	1992-09-22	Oncotech, Inc.	Immunopotentiating protocol for chemotherapy-responsive tumors
US5364875A (en)	1992-05-11	1994-11-15	The Du Pont Merck Pharmaceutical Company	Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en)	1992-05-11	1994-05-10	The Du Pont Merck Pharmaceutical Company	Imidazoles for the treatment of atherosclerosis
US5290801A (en)	1992-05-29	1994-03-01	The Du Pont Merck Pharmaceutical Company	Benzimidazoles for the treatment of atherosclerosis
KR950702994A (ko)	1992-08-12	1995-08-23	로렌스 티. 웰츠	탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
PL310895A1 (en)	1993-03-31	1996-01-08	Merck & Co Inc	Hiv protease inhibitors in aids treating pharmaceutic compositions
US5434163A (en)	1993-05-14	1995-07-18	The Medical College Of Pennsylvania	Treatment of Cryptococcus neoformans infection
JP3213471B2 (ja)	1994-04-13	2001-10-02	ポーラ化成工業株式会社	薬効成分含有リポソーム製剤の製造方法
ZA962880B (en)	1995-04-12	1997-03-17	Procter & Gamble	A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5665713A (en)	1995-04-12	1997-09-09	Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5629341A (en)	1995-04-12	1997-05-13	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
ATE367808T1 (de)	1995-04-12	2007-08-15	Uaf Technologies And Res Llc	N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
NZ305784A (en)	1995-04-12	2001-03-30	Procter & Gamble	Benzimidazole containing medicaments for treating cancers, tumors and viral infections
ZA962879B (en)	1995-04-12	1997-03-17	Procter & Gamble	A pharmaceutical composition for inhibiting the growth of viruses and cancers
US5656615A (en)	1995-04-12	1997-08-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
CN1186433A (zh)	1995-06-07	1998-07-01	普罗克特和甘保尔公司	苯并咪唑类在制备白血病治疗药物上的应用
MX9707809A (es)	1995-06-07	1998-01-31	Procter & Gamble	Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6200992B1 (en)	1995-06-07	2001-03-13	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US5665751A (en)	1995-06-07	1997-09-09	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
BR9609920A (pt)	1995-08-03	1999-07-06	Procter & Gamble	Uso de griseofulvina para inibir o crescimento de cânceres
US5908855A (en)	1996-07-16	1999-06-01	The Procter & Gamble Company	Compositions for treating viral infections
AU711966B2 (en)	1995-08-04	1999-10-28	Procter & Gamble Company, The	Use of fluconazole for inhibiting the growth of cancers
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
PE11499A1 (es)	1997-05-16	1999-03-01	Procter & Gamble	Tratamiento del hiv y cancer
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment

1999
- 1999-05-17 US US09/312,949 patent/US6245789B1/en not_active Expired - Fee Related
- 1999-05-19 EP EP99923219A patent/EP1079831A1/en not_active Withdrawn
- 1999-05-19 HU HU0103319A patent/HUP0103319A2/hu unknown
- 1999-05-19 SK SK1744-2000A patent/SK17442000A3/sk unknown
- 1999-05-19 JP JP2000549250A patent/JP2002515432A/ja not_active Withdrawn
- 1999-05-19 PL PL99344223A patent/PL344223A1/xx unknown
- 1999-05-19 WO PCT/US1999/011059 patent/WO1999059585A1/en not_active Ceased
- 1999-05-19 AU AU40042/99A patent/AU4004299A/en not_active Abandoned
- 1999-05-19 CN CN99806363A patent/CN1301158A/zh active Pending
- 1999-05-19 CO CO99030834A patent/CO5050303A1/es unknown
- 1999-05-19 CA CA002329877A patent/CA2329877A1/en not_active Abandoned
- 1999-05-19 BR BR9911043-1A patent/BR9911043A/pt not_active IP Right Cessation
- 1999-05-19 AR ARP990102384A patent/AR019305A1/es unknown
- 1999-05-19 PE PE1999000422A patent/PE20000550A1/es not_active Application Discontinuation
- 1999-05-19 TR TR2000/03383T patent/TR200003383T2/xx unknown
- 1999-05-19 KR KR1020007012938A patent/KR20010043709A/ko not_active Ceased
- 1999-05-19 IL IL13900299A patent/IL139002A0/xx unknown
- 1999-05-19 ID IDW20002656A patent/ID27457A/id unknown
2000
- 2000-11-17 NO NO20005839A patent/NO20005839L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1301158A (zh)	2001-06-27
NO20005839D0 (no)	2000-11-17
TR200003383T2 (tr)	2001-03-21
CA2329877A1 (en)	1999-11-25
CO5050303A1 (es)	2001-06-27
AR019305A1 (es)	2002-02-13
JP2002515432A (ja)	2002-05-28
BR9911043A (pt)	2001-02-13
KR20010043709A (ko)	2001-05-25
PE20000550A1 (es)	2000-06-29
IL139002A0 (en)	2001-11-25
PL344223A1 (en)	2001-10-08
HUP0103319A2 (hu)	2002-05-29
EP1079831A1 (en)	2001-03-07
US6245789B1 (en)	2001-06-12
ID27457A (id)	2001-04-12
WO1999059585A1 (en)	1999-11-25
SK17442000A3 (sk)	2001-08-06
AU4004299A (en)	1999-12-06

Legal Events

Date	Code	Title	Description
2003-01-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20005839L (no)	2001-01-16	Preparater for behandling av HIV og andre virale infeksjoner
MX2024015459A (es)	2025-02-10	Compuestos de carbamoilpiridona triciclica puenteada y su uso farmaceutico
NO20052130L (no)	2005-04-29	Sterk inhibitor for HCV-serin-protease
TW200500374A (en)	2005-01-01	2' and 3' -nucleoside produrgs for treating flavivridae infections
WO2004003000A3 (en)	2004-11-04	1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
EA200800932A1 (ru)	2008-10-30	Модифицированные 4`-нуклеозиды в качестве противовирусных агентов
EA200600582A1 (ru)	2006-08-25	Способы и композиции для лечения вирусного гепатита с
CO5160294A1 (es)	2002-05-30	Composicion farmaceutica que inhibe o detiene el crecimiento de virus en animales particularmente mamiferos sarrollo de virus en animales y composiciones farmaceuticas que los contienen
WO1998056761A3 (en)	1999-04-15	Benzimidazole derivatives
RU2011127080A (ru)	2013-02-20	Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич
TW200630344A (en)	2006-09-01	Tetracyclic indole derivatives as antiviral agents
SG171596A1 (en)	2011-06-29	Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
RU95107403A (ru)	1996-11-20	Бензоксазиноновые соединения, фармацевтические композиции, способы ингибирования обратной транскритазы, профилактики или лечения, синергистические комбинации и способ получения (-)-6-хлор-4-циклопропилэтинил-4-трифторметил-1,4-дигидро-2н-3,1-бензоксазин-2-она
MXPA02001571A (es)	2003-10-14	Metodo de tratamiento para el cancer.
MXPA06000418A (es)	2006-04-05	Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral.
WO2004037784A3 (en)	2004-08-19	Pyrrolidones with anti-hiv activity
WO2021055425A3 (en)	2021-04-29	Functionalized heterocycles as antiviral agents
CA2365495A1 (en)	2000-10-05	Viral treatment
NO975660L (no)	1998-02-09	Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av leukemi
WO2007106450A3 (en)	2009-04-02	Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy
WO2006083553A3 (en)	2007-04-19	Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
WO2002041891A3 (en)	2003-05-22	Hiv treatment with benzimidazoles
WO2007098247A3 (en)	2007-11-22	Substituted taraxastanes useful for treating viral infections
MXPA02012725A (es)	2004-09-10	Composicion antiviral.
ATE152717T1 (de)	1997-05-15	Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen